Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.74 USD 4.19%
Market Cap: 16.5m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Net Margin
Trinity Biotech PLC

-38%
Current
-35%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-38%
=
Net Income
-22.3m
/
Revenue
58.7m

Net Margin Across Competitors

Country IE
Market Cap 15.4m USD
Net Margin
-38%
Country US
Market Cap 201.2B USD
Net Margin
14%
Country US
Market Cap 183.9B USD
Net Margin
29%
Country US
Market Cap 140.5B USD
Net Margin
16%
Country US
Market Cap 128.1B USD
Net Margin
11%
Country IE
Market Cap 113.4B USD
Net Margin
12%
Country US
Market Cap 67.4B USD
Net Margin
7%
Country DE
Market Cap 58.8B EUR
Net Margin
8%
Country CN
Market Cap 340.9B CNY
Net Margin
34%
Country US
Market Cap 40B USD
Net Margin N/A
Country US
Market Cap 39.9B USD
Net Margin
9%

Profitability Report

View the profitability report to see the full profitability analysis for Trinity Biotech PLC.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-38%
=
Net Income
-22.3m
/
Revenue
58.7m
What is the Net Margin of Trinity Biotech PLC?

Based on Trinity Biotech PLC's most recent financial statements, the company has Net Margin of -38%.